First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients

First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients

Summary: This study evaluated the safety and feasibility of transendocardial injections of VentriGel, a cardiac extracellular matrix hydrogel, in early and late post–myocardial infarction (MI) patients with left ventricular (LV) dysfunction. VentriGel was delivered in 15 patients with moderate LV dy...

Full description

Bibliographic Details
Main Authors: Jay H. Traverse, MD, Timothy D. Henry, MD, Nabil Dib, MD, Amit N. Patel, MD, Carl Pepine, Gary L. Schaer, MD, Jessica A. DeQuach, PhD, Adam M. Kinsey, PhD, Paul Chamberlin, MD, Karen L. Christman, PhD
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:JACC: Basic to Translational Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2452302X1930227X

Internet

http://www.sciencedirect.com/science/article/pii/S2452302X1930227X

Similar Items